Impax's Generic Amrix Must Stay Banned: Cephalon, Mylan

By Ryan Davis · December 12, 2011, 7:09 PM EST

Cephalon Inc. and Mylan Inc. fired back Friday at Impax Laboratories Inc.'s bid to have itself excluded from an injunction barring generic versions of Cephalon's muscle relaxant Amrix, saying Impax is...

To view the full article, register now.

Documents

Case Information

Case Title

In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation

Case Number

1:09-md-02118

Court

Delaware

Nature of Suit

Patent

Date Filed

December 01, 2009